|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.210 USD | -5.82% |
|
-2.77% | +24.93% |
| Market Cap | 736M 647M 599M 551M 1.04B 70.36B 1.06B 7.15B 2.8B 34.5B 2.76B 2.7B 120B | P/E 2026 * |
3.79x | P/E 2027 * | 3.62x |
|---|---|---|---|---|---|
| Enterprise Value | 736M 647M 599M 551M 1.04B 70.36B 1.06B 7.15B 2.8B 34.5B 2.76B 2.7B 120B | EV / Sales 2026 * |
1.6x | EV / Sales 2027 * | 1.54x |
| Free-Float |
96.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | -5.82% | ||
| 1 week | -2.77% | ||
| 1 month | +15.34% | ||
| 3 months | +15.98% | ||
| 6 months | -5.82% | ||
| Current year | +24.93% |
| 1 week | 4.14 |  | 4.88 |
| 1 month | 3.49 | | 4.88 |
| Current year | 2.95 | | 5.78 |
| 1 year | 0.67 | | 5.78 |
| 3 years | 0.53 | | 15.7 |
| 5 years | 0.53 | | 15.7 |
| 10 years | 0.53 | | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 11/03/2021 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 14/05/2026 |
Rosario Lobrutto
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 03/06/2021 |
Julie McHugh
CHM | Chairman | 61 | 31/03/2019 |
Marla Kessler
BRD | Director/Board Member | 56 | 31/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-06 | Sell | Chief Financial Officer | -127,890 | 0.0777% | ||
| 06-15 | Free | Chairman | 85,052 | 0.0517% | ||
| 06-15 | Free | Director | 63,481 | 0.0386% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.82% | -2.77% | +459.62% | -59.28% | 736M | |
| +0.40% | -4.27% | +48.79% | +15.41% | 305B | |
| +0.11% | -3.98% | +23.98% | -6.58% | 69.44B | |
| -0.12% | -4.20% | +33.18% | +104.65% | 9.04B | |
| -0.42% | -1.26% | +6.05% | +2.14% | 8.56B | |
| -3.76% | -8.00% | -19.33% | +7.60% | 4.3B | |
| -2.06% | -11.52% | +11.75% | +27.07% | 4.09B | |
| -0.58% | -3.27% | -39.03% | +20.58% | 3.4B | |
| -2.29% | -1.46% | +42.96% | +55.25% | 2.81B | |
| +0.49% | -1.85% | +10.78% | -21.01% | 2.14B | |
| Average | -1.40% | -2.03% | +57.87% | +14.58% | 40.96B | |
| Weighted average by Cap. | +0.22% | -4.36% | +42.03% | +13.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 459M 404M 374M 344M 650M 43.93B 664M 4.46B 1.75B 21.54B 1.73B 1.69B 74.63B | 478M 420M 389M 358M 677M 45.74B 691M 4.65B 1.82B 22.43B 1.8B 1.76B 77.7B |
| Net income | 188M 165M 153M 141M 266M 18B 272M 1.83B 715M 8.83B 707M 691M 30.57B | 210M 184M 171M 157M 297M 20.07B 303M 2.04B 798M 9.84B 788M 771M 34.09B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | US$4.210 | -5.82% | 2,260,154 |
| 10/07/26 | US$4.470 | -4.28% | 2,775,825 |
| 09/07/26 | US$4.670 | -2.10% | 3,141,607 |
| 08/07/26 | US$4.770 | +6.71% | 4,987,325 |
| 07/07/26 | US$4.470 | +2.05% | 3,479,056 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
